Search International and National Patent Collections
|1. (WO2018036435) HYBRIDOMA CELL STRAIN SCCA1, MONOCLONAL ANTIBODY SECRETED THEREBY, AND APPLICATION OF SAME|
|Applicants:||RAYBIOTECH, INC. GUANGZHOU
|Title:||HYBRIDOMA CELL STRAIN SCCA1, MONOCLONAL ANTIBODY SECRETED THEREBY, AND APPLICATION OF SAME|
A hybridoma cell strain SCCA1, a monoclonal antibody secreted thereby, and application of same. The collection number of the hybridoma cell strain SCCA1 is CCTCC No: C2016131. The monoclonal antibody is secreted by the hybridoma cell strain SCCA1, and may be used in the preparation of a reagent for detecting a cervical cancer. The monoclonal antibody is highly specific. An in vitro diagnostic kit for detecting the cervical cancer built on the basis of the monoclonal antibody has a high detection speed, uses only a small amount of blood sample, and provides highly sensitive detection results. The in vitro diagnostic kit provides a rapid, specific, and sensitive detecting method for different clinical and practical requirements, and greatly improves cervical cancer monitoring and management.